Gilead Sciences Announces Second Quarter 2017 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the second quarter of 2017. The dividend is payable on June 29, 2017, to stockholders of record at the close of business on June 16, 2017. Future dividends will be subject to Board approval.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170502006379/en/

Investors
Gilead Sciences, Inc.
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
• NS Pharma Parent Company, Nippon Shinyaku, Announces Sponsored Research Agreement with Boston Children's Hospital
• Operation HOPE Global Initiative Expands HOPE AI with Support from Martin Eichenfels and Annika Rosenberg